263 related articles for article (PubMed ID: 24726263)
1. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
Trivedi A; Cartun RW; Ligato S
Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
[TBL] [Abstract][Full Text] [Related]
3. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
5. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
[TBL] [Abstract][Full Text] [Related]
6. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.
Chen WH; Huang YL; Chao YK; Yeh CJ; Chang HK; Tseng CK; Liu YH
Ann Surg Oncol; 2015 Jan; 22(1):338-43. PubMed ID: 25023545
[TBL] [Abstract][Full Text] [Related]
8. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K; Makuuchi H; Ogura G
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30883635
[TBL] [Abstract][Full Text] [Related]
10. Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis.
Nguyen CL; Tovmassian D; Isaacs A; Falk GL
Dis Esophagus; 2024 Jun; 37(6):. PubMed ID: 38391209
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion and nodal metastasis in intramucosal adenocarcinoma of the esophagus and esophagogastric junction.
Li ZG; Zhu H; Shi H; Xie H; Goldblum JR; Thota PN; Liu X
J Dig Dis; 2015 Apr; 16(4):197-204. PubMed ID: 25620066
[TBL] [Abstract][Full Text] [Related]
13. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma.
Choi JY; Park YS; Jung HY; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Lee GH; Cho KJ; Kim JH
Gastrointest Endosc; 2011 May; 73(5):881-9, 889.e1-2. PubMed ID: 21392755
[TBL] [Abstract][Full Text] [Related]
15. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
16. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
Saunders JH; Al-Zubaidi S; Waller RC; Ortiz-Fernandez-Sordo J; Parsons SL; Ragunath K; Kaye PV;
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32090253
[TBL] [Abstract][Full Text] [Related]
17. Additive lymph node dissection may be necessary in minute submucosal cancer of the stomach after endoscopic resection.
Kim JH; Lee YC; Kim H; Yoon SO; Kim H; Youn YH; Park H; Lee SI; Choi SH; Noh SH
Ann Surg Oncol; 2012 Mar; 19(3):779-85. PubMed ID: 21964889
[TBL] [Abstract][Full Text] [Related]
18. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers predicting lymph node metastasis in early esophageal cancer.
Plum PS; Warnecke-Eberz U; Dhaouadi O; Alakus H; Drebber U; Metzger R; Prenzel KL; Hölscher AH; Bollschweiler E
Histol Histopathol; 2015 Oct; 30(10):1193-202. PubMed ID: 25869644
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
